decreased interleukin-12b secretion_Tlr9<tm1Aki>/Tlr9<tm1Aki>

http://metadb.riken.jp/0008670B6129P2Tlr9tm1AkiTlr9tm1AkiTlr9tm1AkiTlr9tm1Aki

decreased interleukin-12b secretion_Tlr9<tm1Aki>/Tlr9<tm1Aki>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• toll-like receptor 9
  http://metadb.riken.jp/db/mgi_rdf/MGI:1932389

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tlr9<tm1Aki>/Tlr9<tm1Aki>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tlr9<tm1Aki>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129P2-Tlr9<tm1Aki>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased interleukin-12b secretion
  http://purl.obolibrary.org/obo/MP_0008670

文献

http://purl.org/net/cito/citesAsAuthority

• Ulrike. Schleicher, et.al., NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs., The Journal of experimental medicine, 2007, 204
  http://rdf.ncbi.nlm.nih.gov/pubmed/17389237
• Troy. Querec, et.al., Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity., The Journal of experimental medicine, 2006, 203
  http://rdf.ncbi.nlm.nih.gov/pubmed/16461338